These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7554101)

  • 21. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
    Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
    Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of microtubule inhibitors-taxol, vinblastine and estramustine on the growth and p53 gene expression in the hormone independent human prostatic JCA-1 cells.
    Darby E; An S; Ng C; Hsieh TC; Mallouh C; Wu JM
    Anticancer Res; 1996; 16(6B):3647-52. PubMed ID: 9042236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.
    Piedagnel R; Tiger Y; Lelongt B; Ronco PM
    J Cell Physiol; 2006 Feb; 206(2):394-401. PubMed ID: 16155905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estramustine induces disorganization of microtubules, perinuclear retraction of vimentin and endoplasmatic reticulum, and inhibits cell migration.
    Rutberg M; Wallin M
    Acta Histochem; 1993 Dec; 95(2):155-67. PubMed ID: 8135088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
    Lijnen HR; Wagner EF; Collen D
    Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
    Ueshima S; Fukao H; Okada K; Matsuo O
    Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucosamine sulfate suppresses the expressions of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Lee CY; Chou MC; Lu KH
    Clin Chim Acta; 2006 Oct; 372(1-2):167-72. PubMed ID: 16756968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells.
    Silvy M; Giusti C; Martin PM; Berthois Y
    Br J Cancer; 2001 Apr; 84(7):936-45. PubMed ID: 11286474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of estramustine phosphate with microtubule-associated proteins.
    Wallin M; Deinum J; Fridén B
    FEBS Lett; 1985 Jan; 179(2):289-93. PubMed ID: 2857133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhazinilam mimics the cellular effects of taxol by different mechanisms of action.
    David B; Sévenet T; Morgat M; Guénard G; Moisand A; Tollon Y; Thoison O; Wright M
    Cell Motil Cytoskeleton; 1994; 28(4):317-26. PubMed ID: 7954858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EB1, a protein which interacts with the APC tumour suppressor, is associated with the microtubule cytoskeleton throughout the cell cycle.
    Morrison EE; Wardleworth BN; Askham JM; Markham AF; Meredith DM
    Oncogene; 1998 Dec; 17(26):3471-7. PubMed ID: 10030671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunofluorescent studies of the anti-microtubule effects of the anti-cancer drug estramustine.
    Wang M; Tew KD; Stearns ME
    Anticancer Res; 1987; 7(6):1165-71. PubMed ID: 3327449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of urokinase-type plasminogen activator and metalloproteinase activities in cultured mouse mammary-carcinoma cells: enhancement by paclitaxel and inhibition by nocodazole.
    Alonso DF; Farina HG; Arregui C; Aon MA; Gomez DE
    Int J Cancer; 1999 Oct; 83(2):242-6. PubMed ID: 10471534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estramustine Phosphate Inhibits TGF-
    Mojsilovic SS; Mojsilovic S; Bjelica S; Santibanez JF
    Anal Cell Pathol (Amst); 2018; 2018():3134102. PubMed ID: 30245956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.
    Stearns ME; Wang M; Tew KD; Binder LI
    J Cell Biol; 1988 Dec; 107(6 Pt 2):2647-56. PubMed ID: 3060470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antineoplastic agent estramustine and the derivative estramustine-phosphate inhibit secretion of interleukin-3 in leukemic cells. Possible roles of MAPs.
    Martínez J; Santibáñez JF; Vial C; Maccioni RB
    Mol Cell Biochem; 1992 Nov; 117(2):165-73. PubMed ID: 1488050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Charge dependency of the effects of estramustine derivatives on microtubule assembly in vitro.
    Wallin M; Fridén B; Rutberg M; Deinum J
    Acta Histochem Suppl; 1991; 41():45-53. PubMed ID: 1811268
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of estramustine on microtubuli is different from the direct action via oxygen radicals on DNA and cell membrane.
    Henriksson R; Bjermer L; Von Schoultz E; Grankvist K
    Anticancer Res; 1990; 10(2A):303-9. PubMed ID: 2346305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study.
    Yoshida D; Piepmeier JM; Bergenheim T; Henriksson R; Teramoto A
    Br J Cancer; 1998; 77(1):21-5. PubMed ID: 9459141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective antimitotic effects of estramustine correlate with its antimicrotubule properties on glioblastoma and astrocytes.
    Yoshida D; Cornell-Bell A; Piepmeier JM
    Neurosurgery; 1994 May; 34(5):863-7; discussion 867-8. PubMed ID: 8052384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.